The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2024
DOI: 10.1111/dme.15319
|View full text |Cite
|
Sign up to set email alerts
|

Berberine attenuates obesity‐induced insulin resistance by inhibiting miR‐27a secretion

Junda Du,
Yu Zhu,
Xuehan Yang
et al.

Abstract: IntroductionBerberine (BBR) is an alkaloid found in plants. It has neuroprotective, anti‐inflammatory and lipid‐lowering activity. However, the efficacy of treatment with BBR and the mechanisms through which it acts need further study.AimsThis study investigated the therapeutic effects and the mechanism of action of BBR on obesity‐induced insulin resistance in peripheral tissues.MethodsHigh‐fat‐fed C57BL/6J mice and low‐fat‐fed C57BL/6J mice with miR‐27a overexpression were given BBR intervention (100 mg/kg, p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 39 publications
(65 reference statements)
0
0
0
Order By: Relevance
“…FATP1 exhibits high expression levels in hormone-sensitive tissues, such as WAT, where insulin is required for FATP1 to facilitate fatty acid (FA) uptake. FATP4 facilitates FA uptake not just in insulin-sensitive tissues but also in insulin-insensitive tissues [ 48 , 49 , 50 ], as in the case of our experimental condition, in which the widely renowned model of PA-induced insulin resistance determines the reduction of FATP levels. Impaired lipid trafficking caused by PA was recovered by the OLE and COMBO treatments, which were able to restore both FATP1–4 levels compared to the PA-challenged group, suggesting their potential in maintaining basal adipocyte lipid import.…”
Section: Discussionmentioning
confidence: 99%
“…FATP1 exhibits high expression levels in hormone-sensitive tissues, such as WAT, where insulin is required for FATP1 to facilitate fatty acid (FA) uptake. FATP4 facilitates FA uptake not just in insulin-sensitive tissues but also in insulin-insensitive tissues [ 48 , 49 , 50 ], as in the case of our experimental condition, in which the widely renowned model of PA-induced insulin resistance determines the reduction of FATP levels. Impaired lipid trafficking caused by PA was recovered by the OLE and COMBO treatments, which were able to restore both FATP1–4 levels compared to the PA-challenged group, suggesting their potential in maintaining basal adipocyte lipid import.…”
Section: Discussionmentioning
confidence: 99%